Search

Your search keyword '"Jornayvaz FR"' showing total 169 results

Search Constraints

Start Over You searched for: Author "Jornayvaz FR" Remove constraint Author: "Jornayvaz FR"
169 results on '"Jornayvaz FR"'

Search Results

101. [Gestational diabetes--what are the non-medical approaches?].

102. Low birth weight leads to obesity, diabetes and increased leptin levels in adults: the CoLaus study.

103. Diabetes Mellitus Is Associated With Reduced High-Density Lipoprotein Sphingosine-1-Phosphate Content and Impaired High-Density Lipoprotein Cardiac Cell Protection.

104. Second-generation antisense oligonucleotides against β-catenin protect mice against diet-induced hepatic steatosis and hepatic and peripheral insulin resistance.

105. [News in diabetology 2015].

106. Leptin as a Potential Regulator of FGF21.

107. Metabolic syndrome and nonalcoholic fatty liver disease: Is insulin resistance the link?

108. [Management of cardiovascular diseases in adults from 1999 to 2014: what has really changed?].

109. Endocrine causes of nonalcoholic fatty liver disease.

110. Hepatic insulin resistance and increased hepatic glucose production in mice lacking Fgf21.

111. Serum Vitamin D Concentrations Are Not Associated with Insulin Resistance in Swiss Adults.

112. [Artificial sweeteners and diabetes: friends or foes?].

113. [Diabetes in 2015: constantly increasing, but with enlarged therapeutics options].

114. [Metformin: new data for an old molecule].

115. [Classification of diabetes: an increasing heterogeneity].

116. Ketogenic Diet Impairs FGF21 Signaling and Promotes Differential Inflammatory Responses in the Liver and White Adipose Tissue.

117. ApoA5 knockdown improves whole-body insulin sensitivity in high-fat-fed mice by reducing ectopic lipid content.

118. [Transition in diabetology].

119. Free Fatty Acids Impair FGF21 Action in HepG2 Cells.

120. [Combined treatment of insulin and GLP-1 analogs: what do we expect?].

121. [Chronic liver diseases and diabetes].

122. Muscle-specific activation of Ca(2+)/calmodulin-dependent protein kinase IV increases whole-body insulin action in mice.

123. Diets and nonalcoholic fatty liver disease: the good and the bad.

124. Ostα-/- mice exhibit altered expression of intestinal lipid absorption genes, resistance to age-related weight gain, and modestly improved insulin sensitivity.

126. Increased FGF21 plasma levels in humans with sepsis and SIRS.

127. Cellular mechanisms by which FGF21 improves insulin sensitivity in male mice.

128. Inflammation as a potential link between nonalcoholic fatty liver disease and insulin resistance.

129. Enhanced fasting glucose turnover in mice with disrupted action of TUG protein in skeletal muscle.

130. [Sport and type 1 diabetes].

131. Cellular mechanism by which estradiol protects female ovariectomized mice from high-fat diet-induced hepatic and muscle insulin resistance.

132. Non-alcoholic fatty liver disease and insulin resistance: from bench to bedside.

133. CGI-58 knockdown sequesters diacylglycerols in lipid droplets/ER-preventing diacylglycerol-mediated hepatic insulin resistance.

134. A rare cause of hypertestosteronemia in a 68-year-old patient: a Leydig cell tumor due to a somatic GNAS (guanine nucleotide-binding protein, alpha-stimulating activity polypeptide 1)-activating mutation.

135. Development of insulin resistance in mice lacking PGC-1α in adipose tissues.

136. [Sleep and diabetes].

137. [Diabetes and non-alcoholic fatty liver disease].

138. Diacylglycerol activation of protein kinase Cε and hepatic insulin resistance.

139. Thyroid hormone receptor-α gene knockout mice are protected from diet-induced hepatic insulin resistance.

140. Dissociation of inositol-requiring enzyme (IRE1α)-mediated c-Jun N-terminal kinase activation from hepatic insulin resistance in conditional X-box-binding protein-1 (XBP1) knock-out mice.

141. Apolipoprotein CIII overexpressing mice are predisposed to diet-induced hepatic steatosis and hepatic insulin resistance.

142. Influence of the hepatic eukaryotic initiation factor 2alpha (eIF2alpha) endoplasmic reticulum (ER) stress response pathway on insulin-mediated ER stress and hepatic and peripheral glucose metabolism.

144. Deletion of the mammalian INDY homolog mimics aspects of dietary restriction and protects against adiposity and insulin resistance in mice.

145. Hepatic insulin resistance in mice with hepatic overexpression of diacylglycerol acyltransferase 2.

146. Pregnancy does not accelerate corticotroph tumor progression in Nelson's syndrome.

147. Targeted expression of catalase to mitochondria prevents age-associated reductions in mitochondrial function and insulin resistance.

148. A high-fat, ketogenic diet causes hepatic insulin resistance in mice, despite increasing energy expenditure and preventing weight gain.

149. The role of muscle insulin resistance in the pathogenesis of atherogenic dyslipidemia and nonalcoholic fatty liver disease associated with the metabolic syndrome.

150. Effects of the peroxisome proliferator-activated receptor (PPAR)-gamma agonist pioglitazone on renal and hormonal responses to salt in diabetic and hypertensive individuals.

Catalog

Books, media, physical & digital resources